Welcome to LookChem.com Sign In|Join Free

CAS

  • or
ENISOPROST is an antisecretory prostaglandin derivative and an analogue of Prostaglandin E1 (P838600), which is the primary prostaglandin that is easily crystallized from purified biological extracts.

81026-63-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 81026-63-3 Structure
  • Basic information

    1. Product Name: ENISOPROST
    2. Synonyms: ENISOPROST;Prosta-4,13-dien-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (4Z,11alpha,13E)-(+-)-;SC-34301
    3. CAS NO:81026-63-3
    4. Molecular Formula: C22H36O5
    5. Molecular Weight: 380.521
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 81026-63-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 490.2°C at 760 mmHg
    3. Flash Point: 158.2°C
    4. Appearance: /
    5. Density: 1.092g/cm3
    6. Vapor Pressure: 1.15E-11mmHg at 25°C
    7. Refractive Index: 1.536
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 13.90±0.60(Predicted)
    11. CAS DataBase Reference: ENISOPROST(CAS DataBase Reference)
    12. NIST Chemistry Reference: ENISOPROST(81026-63-3)
    13. EPA Substance Registry System: ENISOPROST(81026-63-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 81026-63-3(Hazardous Substances Data)

81026-63-3 Usage

Uses

Used in Pharmaceutical Industry:
ENISOPROST is used as a pharmaceutical agent for its antisecretory properties, helping to reduce the secretion of gastric acid and protect the stomach lining. This makes it useful in the treatment of various gastrointestinal disorders, such as peptic ulcers and gastroesophageal reflux disease (GERD).

Check Digit Verification of cas no

The CAS Registry Mumber 81026-63-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,0,2 and 6 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 81026-63:
(7*8)+(6*1)+(5*0)+(4*2)+(3*6)+(2*6)+(1*3)=103
103 % 10 = 3
So 81026-63-3 is a valid CAS Registry Number.
InChI:InChI=1/C22H36O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h6-7,10,12,17-18,20,24,26H,4-5,8-9,11,13-16H2,1-3H3/b7-6+,12-10+/t17-,18-,20-,22?/m1/s1

81026-63-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name ENISOPROST

1.2 Other means of identification

Product number -
Other names Prosta-4,13-dien-1-oic acid,11,16-dihydroxy-16-methyl-9-oxo-,methyl ester,(4Z,11alpha,13E)-(+-)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:81026-63-3 SDS

81026-63-3Downstream Products

81026-63-3Relevant articles and documents

Synthesis and gastric antisecretory properties of 4,5-unsaturated derivatives of 15-deoxy-16-hydroxy-16-methylprostaglandin E1

Collins,Dajani,Pappo,Gasiecki,Bianchi,Woods

, p. 786 - 790 (2007/10/02)

The synthesis and gastric antisecretory activities of the Δ4,5-cis, Δ4,5-trans, and 4,5-acetylenic analogues of 15-deoxy-16-hydroxy-16-methyl prostaglandin E1 methyl ester are described. The key step in the preparation of these compounds involved the stereospecific conjugate addition of a cuprate reagent to the appropriate cyclopentenones. Although the trans and acetylenic derivatives were weak inhibitors of gastric acid secretion, the cis olefin was more potent and longer acting than the saturated parent compound. Selectivity with respect to unwanted diarrheagenic effects was found to be improved over that of both the parent 16-hydroxy compound and the reference standards, (15S)-15-methyl- and 16,16-dimethylprostaglandin E2.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 81026-63-3